EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Semaphorin 3E–Plexin D1 Axis Drives Lung Fibrosis through ErbB2‐Mediated Fibroblast Activation

Zhesong Deng, Jinkun Chen, Ruonan Yang, Yuan Zhan, Shanshan Chen, Jiaheng Zhang, Hao Fu, Yiya Gu, Qian Huang, Jixing Wu, Lianyu Shan, Abdelilah Soussi Gounni und 1 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202415007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Zhesong Deng und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases …. Hauptthemen laut MEDLINE: Fibroblasts, Idiopathic Pulmonary Fibrosis, Semaphorins, Erb-b2 Receptor Tyrosine Kinases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Leading talents of public health in Hubei Province, Clinical Collaboration Project of Traditional Chinese and Western Medicine in the Major Difficult Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is characterized by excessive fibroblast recruitment and persistent extracellular matrix deposition at sites of tissue injury, leading to severe morbidity and mortality. However, the precise mechanisms by which fibroblasts contribute to IPF pathogenesis remain poorly understood. The study reveals that Sema3E and its receptor Plexin D1 are significantly overexpressed in the lungs of IPF patients and bleomycin (BLM)‐induced lung fibrotic mice. Elevated plasma levels of Sema3E in IPF patients are negatively correlated with lung function. Importantly, Sema3E in IPF lungs predominantly exists as the P61‐Sema3E. The knockdown of Sema3E or Plexin D1 effectively inhibits fibroblast activation, proliferation, and migration. Mechanistically, Furin‐mediated cleavage of P87‐Sema3E into P61‐Sema3E drives these pro‐fibrotic activities, with P61‐Sema3E‐PlexinD1 axis promoting fibroblast activation, proliferation, and migration by affecting the phosphorylation of ErbB2, which subsequently activates the ErbB2 pathways. Additionally, Furin inhibition reduces fibroblast activity by decreasing P61‐Sema3E production. In vivo, both whole‐lung Sema3E knockdown and fibroblast‐specific Sema3E knockout confer protection against BLM‐induced lung fibrosis. These findings underscore the crucial role of the P61‐Sema3E‐Plexin D1 axis in IPF pathogenesis and suggest that targeting this pathway may hold promise for the development of novel therapeutic strategies for IPF treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibroblastsIdiopathic Pulmonary FibrosisSemaphorinsErb-b2 Receptor Tyrosine KinasesPulmonary FibrosisAnimalsHumansMiceLungCell ProliferationMaleMice, Inbred C57BLDisease Models, AnimalCell MovementBleomycinSignal TransductionFemaleMembrane GlycoproteinsIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

Plexin D1Sema3Eidiopathic pulmonary fibrosismyofibroblast differentiation

Substanzen

SemaphorinsErb-b2 Receptor Tyrosine KinasesBleomycinMembrane GlycoproteinsIntracellular Signaling Peptides and ProteinsSEMA3E protein, humanERBB2 protein, humanPLXND1 protein, human

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, National Clinical Research Center of Respiratory Disease, Key Laboratory of Pulmonary Diseases of Health Ministry, Tongji Hospital, Tongji Medical College, Huazhong…
  • Lawrence Bloomberg, University of Toronto, 155 College Street, Suite 130, Toronto, ON, M5T 1P8, Canada.
  • Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 401122, China.
  • Department of Immunology, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, R3E 0T5, Canada.

ORCID-Profile: Jungang Xie

Förderung

  • National Natural Science Foundation of China
  • Leading talents of public health in Hubei Province
  • Clinical Collaboration Project of Traditional Chinese and Western Medicine in the Major Difficult Diseases
  • Project of Key R&D Program in Hubei Province
  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Deng, Z., Chen, J., Yang, R., Zhan, Y., Chen, S., Zhang, J., Fu, H., Gu, Y., Huang, Q., Wu, J., Shan, L., Gounni, A. S., & Xie, J. (2025). Semaphorin 3E–Plexin D1 Axis Drives Lung Fibrosis through ErbB2‐Mediated Fibroblast Activation. Advanced Science. https://doi.org/10.1002/advs.202415007

Vancouver

Deng Z, Chen J, Yang R, Zhan Y, Chen S, Zhang J, et al. Semaphorin 3E–Plexin D1 Axis Drives Lung Fibrosis through ErbB2‐Mediated Fibroblast Activation. Advanced Science. 2025. doi:10.1002/advs.202415007

BibTeX
@article{Deng2025,
  author = {Deng, Zhesong and Chen, Jinkun and Yang, Ruonan and Zhan, Yuan and Chen, Shanshan and Zhang, Jiaheng and Fu, Hao and Gu, Yiya and Huang, Qian and Wu, Jixing and Shan, Lianyu and Gounni, Abdelilah Soussi and Xie, Jungang},
  title = {Semaphorin 3E–Plexin D1 Axis Drives Lung Fibrosis through ErbB2‐Mediated Fibroblast Activation},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202415007}
}
Kostenlos starten →